TY - JOUR AU - Markman, M. PY - 2003 DA - 2003// TI - Toxicities of the platinum antineoplastic agents JO - Expert Opin Drug Saf VL - 2 UR - https://doi.org/10.1517/14740338.2.6.597 DO - 10.1517/14740338.2.6.597 ID - Markman2003 ER - TY - JOUR AU - Hartmann, J. T. AU - Lipp, H. P. PY - 2003 DA - 2003// TI - Toxicity of platinum compounds JO - Expert Opin Pharmacother VL - 4 UR - https://doi.org/10.1517/14656566.4.6.889 DO - 10.1517/14656566.4.6.889 ID - Hartmann2003 ER - TY - JOUR AU - Pike, I. M. AU - Arbus, M. H. PY - 1992 DA - 1992// TI - Cisplatin overdosage JO - J Clin Oncol VL - 10 ID - Pike1992 ER - TY - JOUR AU - Blakley, B. W. AU - Cohen, J. I. AU - Doolittle, N. D. AU - Muldoon, L. L. AU - Campbell, K. C. AU - Dickey, D. T. AU - Neuwelt, E. A. PY - 2002 DA - 2002// TI - Strategies for prevention of toxicity caused by platinum-based chemotherapy: review and summary of the annual meeting of the Blood-Brain Barrier Disruption Program, Gleneden Beach, Oregon, March 10, 2001 JO - Laryngoscope VL - 112 UR - https://doi.org/10.1097/00005537-200211000-00016 DO - 10.1097/00005537-200211000-00016 ID - Blakley2002 ER - TY - JOUR AU - Chen, C. S. AU - Seidel, K. AU - Armitage, J. O. AU - Fay, J. W. AU - Appelbaum, F. R. AU - Horowitz, M. M. AU - Shpall, E. J. AU - Weiden, P. L. AU - Antman, K. S. AU - Champlin, R. E. AU - Kersey, J. H. AU - Sullivan, K. M. PY - 1997 DA - 1997// TI - Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation JO - Biol Blood Marrow Transplant VL - 3 ID - Chen1997 ER - TY - JOUR AU - Lagrange, J. L. AU - Cassuto-Viguier, E. AU - Barbe, V. AU - Fischel, J. L. AU - Mondain, J. R. AU - Etienne, M. C. AU - Ferrero, J. M. AU - Creisson-Ducray, A. AU - Formento, P. AU - Milano, G. PY - 1994 DA - 1994// TI - Cytotoxic effects of long-term circulating ultrafiltrable platinum species and limited efficacy of haemodialysis in clearing them JO - Eur J Cancer VL - 30A UR - https://doi.org/10.1016/0959-8049(94)00332-Y DO - 10.1016/0959-8049(94)00332-Y ID - Lagrange1994 ER - TY - JOUR AU - Brivet, F. AU - Pavlovitch, J. M. AU - Gouyette, A. AU - Cerrina, M. L. AU - Tchernia, G. AU - Dormont, J. PY - 1986 DA - 1986// TI - Inefficiency of early prophylactic hemodialysis in cis-platinum overdose JO - Cancer Chemother Pharmacol VL - 18 UR - https://doi.org/10.1007/BF00262294 DO - 10.1007/BF00262294 ID - Brivet1986 ER - TY - JOUR AU - Chu, G. AU - Mantin, R. AU - Shen, Y. M. AU - Baskett, G. AU - Sussman, H. PY - 1993 DA - 1993// TI - Massive cisplatin overdose by accidental substitution for carboplatin. Toxicity and management JO - Cancer VL - 72 UR - https://doi.org/3.0.CO;2-U DO - 3.0.CO;2-U ID - Chu1993 ER - TY - JOUR AU - Charlier, C. AU - Kintz, P. AU - Dubois, N. AU - Plomteux, G. PY - 2004 DA - 2004// TI - Fatal overdosage with cisplatin JO - J Anal Toxicol VL - 28 UR - https://doi.org/10.1093/jat/28.2.138 DO - 10.1093/jat/28.2.138 ID - Charlier2004 ER - TY - JOUR AU - Sheikh-Hamad, D. AU - Timmins, K. AU - Jalali, Z. PY - 1997 DA - 1997// TI - Cisplatin-induced renal toxicity: possible reversal by N-acetylcysteine treatment JO - J Am Soc Nephrol VL - 8 ID - Sheikh-Hamad1997 ER - TY - JOUR AU - Wu, Y. J. AU - Muldoon, L. L. AU - Neuwelt, E. A. PY - 2005 DA - 2005// TI - The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway JO - J Pharmacol Exp Ther VL - 312 UR - https://doi.org/10.1124/jpet.104.075119 DO - 10.1124/jpet.104.075119 ID - Wu2005 ER - TY - JOUR AU - Erdlenbruch, B. AU - Pekrun, A. AU - Schiffmann, H. AU - Witt, O. AU - Lakomek, M. PY - 2002 DA - 2002// TI - Topical topic: accidental cisplatin overdose in a child: reversal of acute renal failure with sodium thiosulfate JO - Med Pediatr Oncol VL - 38 UR - https://doi.org/10.1002/mpo.1343 DO - 10.1002/mpo.1343 ID - Erdlenbruch2002 ER - TY - JOUR AU - Ekborn, A. AU - Hansson, J. AU - Ehrsson, H. AU - Eksborg, S. AU - Wallin, I. AU - Wagenius, G. AU - Laurell, G. PY - 2004 DA - 2004// TI - High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics JO - Laryngoscope VL - 114 UR - https://doi.org/10.1097/00005537-200409000-00030 DO - 10.1097/00005537-200409000-00030 ID - Ekborn2004 ER - TY - JOUR AU - Sastry, J. AU - Kellie, S. J. PY - 2005 DA - 2005// TI - Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose Cisplatin and amifostine JO - Pediatr Hematol Oncol VL - 22 UR - https://doi.org/10.1080/08880010590964381 DO - 10.1080/08880010590964381 ID - Sastry2005 ER - TY - STD TI - ASHP guidelines on preventing medication errors with antineoplastic agents. Am J Health Syst Pharm. 2002, 59 (17): 1648-1668. ID - ref15 ER - TY - STD TI - Criteria for facilities and personnel for the administration of parenteral systemic antineoplastic therapy. Adopted on March 3, 2004 by the American Society of Clinical Oncology. J Clin Oncol. 2004, 22 (22): 4613-4615. 10.1200/JCO.2004.05.077. ID - ref16 ER - TY - JOUR AU - Womer, R. B. AU - Tracy, E. AU - Soo-Hoo, W. AU - Bickert, B. AU - DiTaranto, S. AU - Barnsteiner, J. H. PY - 2002 DA - 2002// TI - Multidisciplinary systems approach to chemotherapy safety: rebuilding processes and holding the gains JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.04.108 DO - 10.1200/JCO.2002.04.108 ID - Womer2002 ER - TY - JOUR AU - Pourrat, X. AU - Antier, D. AU - Crenn, I. AU - Calais, G. AU - Jonville-Bera, A. P. AU - Rouleau, A. PY - 2004 DA - 2004// TI - A prescription and administration error of cisplatin: a case report JO - Pharm World Sci VL - 26 UR - https://doi.org/10.1023/B:PHAR.0000018602.02535.70 DO - 10.1023/B:PHAR.0000018602.02535.70 ID - Pourrat2004 ER - TY - JOUR AU - Choi, J. H. AU - Oh, J. C. AU - Kim, K. H. AU - Chong, S. Y. AU - Kang, M. S. AU - Oh do, Y. PY - 2002 DA - 2002// TI - Successful treatment of cisplatin overdose with plasma exchange JO - Yonsei Med J VL - 43 UR - https://doi.org/10.3349/ymj.2002.43.1.128 DO - 10.3349/ymj.2002.43.1.128 ID - Choi2002 ER - TY - JOUR AU - Jung, H. K. AU - Lee, J. AU - Lee, S. N. PY - 1995 DA - 1995// TI - A case of massive cisplatin overdose managed by plasmapheresis JO - Korean J Intern Med VL - 10 UR - https://doi.org/10.3904/kjim.1995.10.2.150 DO - 10.3904/kjim.1995.10.2.150 ID - Jung1995 ER - TY - JOUR AU - Linenberger, M. L. AU - Price, T. H. PY - 2005 DA - 2005// TI - Use of cellular and plasma apheresis in the critically ill patient: part 1: technical and physiological considerations JO - J Intensive Care Med VL - 20 UR - https://doi.org/10.1177/0885066604271394 DO - 10.1177/0885066604271394 ID - Linenberger2005 ER - TY - JOUR AU - Linenberger, M. L. AU - Price, T. H. PY - 2005 DA - 2005// TI - Use of cellular and plasma apheresis in the critically ill patient: Part II: Clinical indications and applications JO - J Intensive Care Med VL - 20 UR - https://doi.org/10.1177/0885066604273479 DO - 10.1177/0885066604273479 ID - Linenberger2005 ER - TY - JOUR AU - Stegmayr, B. AU - Wikdahl, A. M. PY - 2003 DA - 2003// TI - Access in therapeutic apheresis JO - Ther Apher Dial VL - 7 UR - https://doi.org/10.1046/j.1526-0968.2003.00035.x DO - 10.1046/j.1526-0968.2003.00035.x ID - Stegmayr2003 ER - TY - JOUR AU - Mallat, S. G. AU - Ismail, N. PY - 2002 DA - 2002// TI - Plasmapheresis and related techniques: what should we know JO - J Med Liban VL - 50 ID - Mallat2002 ER - TY - JOUR AU - Rule, A. D. AU - Larson, T. S. AU - Bergstralh, E. J. AU - Slezak, J. M. AU - Jacobsen, S. J. AU - Cosio, F. G. PY - 2004 DA - 2004// TI - Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease JO - Ann Intern Med VL - 141 UR - https://doi.org/10.7326/0003-4819-141-12-200412210-00009 DO - 10.7326/0003-4819-141-12-200412210-00009 ID - Rule2004 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/6/1/prepub UR - http://www.biomedcentral.com/1471-2407/6/1/prepub ID - ref26 ER -